 SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 GLOBE NEWSWIRE -- Sutro Biopharma, Inc. Sutro or the Company NASDAQ: STRO, a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates ADCs, today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. 